Articles tagged with Cancer Treatments
The special issue of Translational Research presents an in-depth view of stem cell research, considering its potential for therapy in various human diseases. Despite scientific and technical advancements, serious ethical concerns remain, including issues of privacy and consent.
A new risk prediction model for venous thromboembolism (VTE) in cancer patients has been developed, incorporating two new biomarkers. The model improves the classification of patients into different risk categories, with a significant increase in accurate predictions of VTE development.
Scientists warn of a global shortage of medical isotopes, used for diagnostic and treatment procedures, putting patient care at risk. The lack of these life-saving materials could lead to less accurate tests, higher radiation doses, and increased healthcare costs.
Researchers at Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. They identified changes in the brain and spinal cord that occur during the development of morphine tolerance, providing a therapeutic target for preventing it.
The US Neurology guidelines provide a framework for diagnosing and treating infantile spasms, with a focus on early intervention and personalized treatment strategies. The consensus among experts is that broad clinical evaluation, vigabatrin or adrenocorticotropic hormone (ACTH) as first-line treatment, and timely assessment of treatme...
A study found that oxygen therapy provides no additional benefit over regular air in relieving persistent breathlessness in patients with life-limiting illness. The researchers suggest less burdensome strategies should be considered for these patients.
A new study from Duke University Medical Center found that half of patients with advanced disease in palliative care settings don't benefit from oxygen therapy, and receiving pure oxygen or room air offers equal relief. The study suggests alternative methods, such as using a small fan, may be equally effective.
Researchers at Salk Institute discover a novel mechanism by which adenovirus disables p53 in infected cells, paving the way for targeted cancer therapies. The study reveals two key proteins, E1B-55K and E4-ORF3, that work together to neutralize p53's tumor suppressor function.
Scientists have created diseased liver cells from human skin samples to model a range of inherited disorders. The breakthrough could lead to personalized treatments and cell-based therapy for those suffering from liver diseases.
A global shortage of medical isotopes, used in diagnostic and therapeutic procedures, poses a threat to patient care and may force doctors to use less accurate tests. The shortage is attributed to the unexpected shutdown of major isotope production facilities, leaving only 10-15% of isotopes produced domestically.
Researchers are investigating the effects of radiation on human bone strength to improve treatment for cancer patients with bone metastases. The study aims to establish the mechanical strength of bone before and after stereotactic radiosurgery, which has been shown to cause high fracture rates in post-treatment patients.
Researchers at Tufts University develop nanoparticles to deliver therapeutic genes to the retina, delaying onset of eye disease and preserving vision. The treatment, using a gene for GDNF, shows temporary but significant protection against photoreceptor cell death.
Researchers at SUNY Downstate Medical Center have identified proteins (Ligatin, MCT-1 and DENR) that can enhance the progression of viruses and cancer cells by promoting eIF2-independent translation initiation. This novel mechanism is a potential target for therapeutic inhibition to counteract viral infections.
A recent study published in JNCI Journal of the National Cancer Institute found that estrogen alone was not associated with increased lung cancer mortality among postmenopausal women. In contrast, combined hormone therapy showed a statistically significant increase in breast cancer incidence and a reduction in colorectal cancer.
Scientists have developed a new approach to deliver therapeutic genes into brain cancer cells, using chlorotoxin from deathstalker scorpion venom and nanoparticles of iron oxide. This method has shown promise in inducing nearly twice the amount of gene expression in brain cancer cells compared to traditional approaches.
Researchers at the University of Minnesota have successfully treated children with recessive dystrophic epidermolysis bullosa, a fatal skin disease, using bone marrow stem cell therapy. The treatment has shown promising results, increasing collagen production and improving skin resistance to blister formation.
A randomized controlled trial found that adding raltegravir to standard antiretroviral therapy had no effect on low-level viral load in HIV-positive individuals. The study suggests that residual viremia may be due to the release of HIV from stable reservoirs, requiring new therapeutic strategies to cure HIV infection.
Magnetic nanoparticles are injected into tumors to generate heat for cancer treatment. Magnetic relaxometry measures the relaxation of magnetic moments to determine particle quantity, allowing for selective tumor treatment.
The SPRINT-1 study found that adding boceprevir to standard hepatitis C treatment can significantly increase the response rate for genotype 1 patients. The addition of boceprevir to peginterferon and ribavirin regimens resulted in higher rates of sustained virological response compared to the control group.
A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana. The study suggests that the enzyme ABHD6 plays a crucial role in degrading this substance, which is produced by the body's own nerve cells.
The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained NCI designation, recognizing its innovative research and excellent patient care. The center will receive a $7.5 million support grant over five years to advance cancer research and provide patients access to promising new treatments.
A study of 342 early-stage lung cancer survivors found that nearly 60% experienced long-term dyspnea, with associated risk factors including reduced physical activity and depression. Targeting post-treatment rehabilitation strategies to improve breathlessness may be effective in improving outcomes.
The Louisiana Tumor Registry has been designated as a SEER Program cancer registry, providing high-quality cancer incidence and survival data. The registry's data is used to inform prevention, early detection, treatment, and survival strategies.
A study by FDA researchers found a higher incidence of malignancy in children using TNF blockers like infliximab and etanercept. The reporting rate for U.S. cases of malignancy in children was 4-18 times the estimated background rate for the general pediatric population.
Researchers found that African women are more likely to develop triple-negative breast cancer, a condition characterized by the absence of estrogen and progesterone receptors. The study suggests that African ancestry may be associated with a higher risk of hereditary predisposition for breast cancer related to BRCA1 gene mutations.
Two studies examine the effects of oral steroids and propranolol on infantile hemangiomas, revealing potential side effects and complications. Researchers aim to develop safer treatment options for this common childhood skin disorder.
Researchers at the University of Edinburgh have developed a method to alter viral conditions, reducing mutation and building resistance. This approach can target multiple viruses simultaneously and is being explored for use in treating influenza.
Scientists discovered that inhibiting a protein called N-cadherin prevents cancer cells from forming groups and migrating. This new approach could lead to more effective therapies for cancer treatment.
Researchers discover unique combinations of cells and mutations that drive the formation of different cancer subtypes, revealing a potential breakthrough in understanding and treating ependymomas. The study also identifies the first gene linked to ependymoma and creates an accurate laboratory model of this disease.
A new study finds that many US states are cutting mental health funding due to budget crises, while others have reduced Medicaid payments. However, a few countries are investing in stimulus-funded services to address recession-related mental health disorders, such as the UK's training of psychotherapists and nurses.
A Michigan State University researcher is using $1.7 million in federal funding to study the role of microRNAs in regulating genes that control cell behavior. The goal is to determine how arsenic exposure leads to tumor development and identify potential treatments.
A new treatment strategy using rituximab has shown comparable benefits to the current standard of care in reducing disease activity and inducing remission for patients with ANCA-associated vasculitis. Early results also suggest improved outcomes for patients with relapsing disease, making this a major treatment advance.
Researchers discover Lgl and Mahjong proteins help identify how healthy cells fight cancer cells. Normal cells surround cancer cells, leading to their death, while cancerous cells break free and divide.
The new guidelines update Osteoporosis Canada's recommendations on vitamin D intake for Canadians, citing the need for more research into optimal doses and safe upper limits. The recommended daily supplements range from 400-1000 IU for adults under 50, with higher doses required for those over 50.
Gene therapy holds promise in treating prostate cancer, but challenges remain in achieving effective treatment. Researchers call for better testing systems and innovative approaches to advance the field. Prostate cancer is a leading cause of cancer death among men in the US.
Researchers found a compound called P7C3 that improves newborn neuron survival and reduces programmed cell death in the brain's memory hub. This discovery offers new hope for treating Alzheimer's disease by targeting the underlying neuroprotective mechanism.
The foundation named 18 new Damon Runyon Fellows for their innovative cancer research, including studies on gene regulation, immune response, and tumor development. The recipients will receive $156,000 each to pursue novel ideas.
The Hebrew University of Jerusalem has been selected to participate in the CREATE program, focusing on cellular and molecular mechanisms of inflammation. The research aims to develop diagnostic/prognostic indicators and novel therapeutics for inflammatory diseases.
Liver transplant patients receiving cyclosporine for immunosuppression are at higher risk of developing de novo cancer, particularly those transplanted in recent years and younger than 50. The study found a significant association between C2 monitoring and increased early de novo cancer risk.
A new study has identified a key role for adrenal glucocorticoids in resetting the internal body clock, a finding that could lead to new treatments for jet lag. The research also highlights the importance of timing and location in regulating circadian rhythms.
African-American women have more advanced breast cancer at diagnosis and poorer survival outcomes compared to non-Hispanic whites. Despite similar surgical care and adjuvant therapy, African-Americans experience lower overall and breast cancer-specific survival rates due to socio-demographic factors.
Research suggests that biologics-naïve Juvenile Idiopathic Arthritis (JIA) patients may have an elevated risk of cancer compared to the general population. The Swedish study found a higher incidence of cancers among paediatric JIA patients identified during the last 40 years.
A recent study found that patients with early-stage lung cancer often forego surgery due to misconceptions about prognosis, communication with doctors, and personal life after treatment. The research also highlights racial disparities in surgical rates among black patients compared to their white counterparts.
Researchers analyzed surgical outcomes of non-small cell lung cancer patients over 30 years, finding improved survival rates with earlier stage diagnoses. The increase in patients diagnosed with early-stage adenocarcinoma is thought to contribute significantly to the favorable results.
A new study reveals that disparities in cancer stage and treatment account for the majority of excess deaths among uninsured and Medicaid-insured rectal cancer patients. Improving insurance coverage and reducing cost-related barriers to primary care and high-quality treatment can help mitigate these disparities.
A new gene on chromosome 13 has been identified as a potential cause of bowel cancer spread and progression. The discovery is based on a large family study that analyzed the genetic profiles of 81 family members over five generations.
A study published in Cancer Research found that high calcium intake, even from non-dairy sources such as soy and green vegetables, may increase prostate cancer risk in Chinese men. The research, which analyzed data from over 27,000 men, showed a 25% increased risk of prostate cancer among those consuming higher amounts of calcium.
Only 5% of cancer research funds are spent on investigating metastases, yet it kills 90% of all cancer patients. The European CanCer Organisation highlights this discrepancy in funding and calls for increased emphasis on tackling metastases.
Researchers found that Wikipedia's cancer information is accurate but poorly readable compared to peer-reviewed sites like the National Cancer Institute's PDQ. Readability was highly statistically significant, with Wikipedia written at a college level while PDQ was suitable for a 9th grader.
Researchers present studies demonstrating progress in using the R.E.N.A.L. Nephrometry Scoring system to standardize surgical decision-making and improve patient outcomes for patients with kidney cancers. The system captures anatomical features of renal masses, allowing for more accurate evaluation of treatment strategies.
Researchers from the University of Navarra have identified a link between specific gene mutations and more severe forms of leukemia. The study analyzed patients from 19 hospitals across Europe, confirming that these genetic alterations can be used to monitor disease progression and identify potential therapeutic targets.
Research reveals that group visits can significantly improve blood pressure in diabetics with hypertension but not blood sugar levels. Colorectal cancer risk increases with age and birth cohort, suggesting a potential burden to society. Opioid treatment agreements may not reduce misuse, and a new complication from contaminated cocaine ...
Researchers found that pancreatic cancer patients with circulating tumor cells tend to have worse outcomes, and some types of cells may predict poorer survival. The presence of MUC1 protein-expressing circulating tumor cells is particularly associated with shorter overall survival.
A recent study found that antiretroviral treatment (ART) significantly reduces the risk of HIV transmission in heterosexual couples, with a 92% lower rate of transmission among those on ART compared to those not on treatment. The greatest benefit was seen in individuals with CD4 counts below 200 cells per μL.
A study found that patients taking bisphosphonates are often uninformed about the drug's possible side effects on oral health, including bisphosphonate-associated osteonecrosis of the jaw (BON). The researchers interviewed 73 participants and discovered that 82% were unsure if their physicians had informed them about potential adverse ...
Two teams of researchers identified biomarkers that predict excellent graft function in kidney transplant recipients who stop taking immunosuppressive drugs. A molecular signature indicative of future organ failure was also found. The signatures may help physicians design personalized treatment regimens for kidney transplant recipients.
Researchers examined the impact of uninterrupted clopidogrel on postpolypectomy bleeding rates and found a significant increase in risk when used with aspirin/nonsteroidal anti-inflammatory drugs, but the overall outcome is favorable and the risk is small.
A recent study by S. Eggener et al. discusses the significance and impact of focal therapy for low-risk prostate cancer patients, highlighting its potential as an alternative to whole-gland treatment. The study reviews patient selection criteria, diagnostic imaging, biopsy schemes, and treatment modalities available for focal therapy.
A recent study found that most patients with localized papillary thyroid cancer can expect favorable outcomes without treatment. The 20-year survival rate for these patients is estimated to be around 97%, similar to those who received treatment. Clinicians and patients can feel comfortable considering observation as an option.
Researchers have identified a previously undiagnosed condition and treated it with a stem cell transplant, saving the patient's life. The key to unlocking the reason for the patient's symptoms was contracting a rare version of glandular fever.